These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2023186)

  • 21. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs].
    Steen KS; Lems WF; Dijkmans BA
    Ned Tijdschr Geneeskd; 1999 Aug; 143(32):1649-52. PubMed ID: 10494299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs].
    Knol A
    Ned Tijdschr Geneeskd; 1999 Nov; 143(46):2339. PubMed ID: 10589226
    [No Abstract]   [Full Text] [Related]  

  • 23. NSAID gastropathy. A new understanding.
    Roth SH
    Arch Intern Med; 1996 Aug 12-26; 156(15):1623-8. PubMed ID: 8694659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative evaluation of the omeprasol and pantoprasol efficacy in treatment of gastropathy induced by non-steroid anti-inflammatory drugs in the patients with rheumatoid arthritis].
    Zufarov PS; Iakubov AV; Salaeva DT
    Lik Sprava; 2009; (3-4):44-9. PubMed ID: 19960588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [2-nd place of Young Scientist's Competition. Basal prostaglandins level in stomach mucous as predictors of NSAID-gastropathy].
    Kim VA
    Eksp Klin Gastroenterol; 2009; (7):114-8. PubMed ID: 20469716
    [No Abstract]   [Full Text] [Related]  

  • 26. [NSAID-gastropathy: state-of-the-art therapy optimization capabilities in outpatient practice].
    Burkov SG; Arutiunov AT; Gurova NIu; Lobanova EG; Nikiforov PA; Okoemov MN; Cherezova IN; Chugunnikova LI
    Eksp Klin Gastroenterol; 2008; (3):97-101. PubMed ID: 19145889
    [No Abstract]   [Full Text] [Related]  

  • 27. Practical management of NSAID gastropathy in rheumatic patients.
    Peltier AP
    Scand J Rheumatol Suppl; 1989; 78():12-7; discussion 30-2. PubMed ID: 2786645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreasing incidence of symptomatic gastrointestinal ulcers and ulcer complications in patients with rheumatoid arthritis.
    Steen KS; Nurmohamed MT; Visman I; Heijerman M; Boers M; Dijkmans BA; Lems WF
    Ann Rheum Dis; 2008 Feb; 67(2):256-9. PubMed ID: 17604285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Celecoxib versus a non-selective NSAID plus proton-pump inhibitor: what are the considerations?
    Chen JT; Pucino F; Resman-Targoff BH
    J Pain Palliat Care Pharmacother; 2006; 20(4):11-32. PubMed ID: 17182503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-inflammatory activity without NSAID-related gastropathy.
    Taha AS
    Gastroenterology; 1994 Jun; 106(6):1726-7. PubMed ID: 8194731
    [No Abstract]   [Full Text] [Related]  

  • 31. [Non-steroid gastropathy combined with Helicobacter pylori: current problems].
    Akhmedov VA; Vinzhegina VA; Sudakova AN; Rozenblit EI
    Eksp Klin Gastroenterol; 2007; (1):64-6. PubMed ID: 17547117
    [No Abstract]   [Full Text] [Related]  

  • 32. The prevention of gastropathy and upper abdominal symptoms caused by nonsteroidal anti-inflammatory drugs.
    Vakil N
    Rev Gastroenterol Disord; 2006; 6(4):221-6. PubMed ID: 17224894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The prevention of nonsteroidal antirheumatic agent-associated gastropathy].
    Hutt HJ; Mielenz H
    Dtsch Med Wochenschr; 1992 Feb; 117(7):281. PubMed ID: 1737567
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacoeconomic aspects of non-steroidal anti-inflammatory drug gastropathy.
    Walan A; Wahlqvist P
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S79-88. PubMed ID: 10379474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gastropathy caused by nonsteriod anti-inflammatory drugs: from understanding of development mechanisms to planning strategy of treatment and prophylaxis].
    Akhmedov VA; Vinzhegina VA; Sudakova AN; Rozenblit EI
    Ter Arkh; 2007; 79(2):81-5. PubMed ID: 17460975
    [No Abstract]   [Full Text] [Related]  

  • 36. Nonsteroidal anti-inflammatory drug gastropathy. Recognition and response.
    Roth SH; Bennett RE
    Arch Intern Med; 1987 Dec; 147(12):2093-100. PubMed ID: 3318750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [NSAID prescription in patients with rheumatoid arthritis and cardiovascular disease].
    Pavlović R; Curković B; Babić-Naglić D; Kehler T
    Reumatizam; 2006; 53(1):22-4. PubMed ID: 17580545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs].
    Salentijn GJ
    Ned Tijdschr Geneeskd; 1999 Nov; 143(46):2340. PubMed ID: 10589227
    [No Abstract]   [Full Text] [Related]  

  • 39. [Non-steroid gastropathy: particular features of treatment].
    Vasil'ev IuV
    Eksp Klin Gastroenterol; 2007; (1):56-9. PubMed ID: 17547115
    [No Abstract]   [Full Text] [Related]  

  • 40. [The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs].
    Fialová P; Vlcek J
    Vnitr Lek; 2004 Nov; 50(11):858-66. PubMed ID: 15648967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.